HUMANA INC

NYSE: HUM (Humana Inc.)

Last update: 20 Mar, 10:06PM

266.83

-0.51 (-0.19%)

  • 1D -0.19%
  • 5D -1.80%
  • 1M 1.54%
  • 6M 11.17%
  • YTD 5.61%
  • 1Y -13.94%
  • 5Y -18.52%
Previous Close 267.34
Open 266.58
Volume 1,069,903
Avg. Volume (3M) 1,566,040
Market Cap 32,204,511,232
Price / Earnings (TTM) 26.74
Price / Earnings (Forward) 16.16
Price / Sales 0.270
Price / Book 1.95
52 Weeks Range
213.31 (-20%) — 406.46 (52%)
Earnings Date 30 Apr 2025
TTM Dividend Yield 1.33%
Profit Margin 1.02%
Operating Margin (TTM) -0.73%
Diluted EPS (TTM) 9.97
Quarterly Revenue Growth (YOY) 10.40%
Quarterly Earnings Growth (YOY) -42.30%
Total Debt/Equity (MRQ) 76.90%
Current Ratio (MRQ) 1.76
Operating Cash Flow (TTM) 2.97 B
Levered Free Cash Flow (TTM) -1.31 B
Return on Assets (TTM) 4.07%
Return on Equity (TTM) 7.41%

Market Trend

Short Term Medium Term
Industry Healthcare Plans (US) Mixed Bearish
Healthcare Plans (Global) Mixed Bearish
Stock Humana Inc. Bullish Bearish

AIStockmoo Score

0.4
Analyst Consensus 1.5
Insider Activity NA
Price Volatility -1.0
Technical Moving Averages -1.0
Technical Oscillators 2.0
Average 0.38

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
HUM 32 B 1.33% 26.74 1.95
CVS 83 B 3.04% 17.95 1.12
CNC 30 B - 9.52 1.13
UNH 490 B 1.57% 34.51 5.17
ELV 98 B 1.53% 16.84 2.33
CI 87 B 1.80% 26.23 2.19

Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Sector Healthcare
Industry Healthcare Plans
Investment Style Mid Value
% Held by Insiders 0.20%
% Held by Institutions 97.83%
52 Weeks Range
213.31 (-20%) — 406.46 (52%)
Price Target Range
256.00 (-4%) — 290.00 (8%)
High 290.00 (Truist Securities, 8.68%) Hold
290.00 (Cantor Fitzgerald, 8.68%) Hold
Median 285.00 (6.81%)
Low 256.00 (JP Morgan, -4.06%) Hold
Average 280.29 (5.04%)
Total 1 Buy, 6 Hold
Avg. Price @ Call 262.00
Firm Date Target Price Call Price @ Call
JP Morgan 18 Feb 2025 256.00 (-4.06%) Hold 257.24
Barclays 13 Feb 2025 270.00 (1.19%) Hold 252.88
22 Jan 2025 255.00 (-4.43%) Hold 284.92
Cantor Fitzgerald 12 Feb 2025 290.00 (8.68%) Hold 260.03
Morgan Stanley 12 Feb 2025 285.00 (6.81%) Hold 260.03
RBC Capital 12 Feb 2025 283.00 (6.06%) Buy 260.03
Piper Sandler 15 Jan 2025 288.00 (7.93%) Hold 279.49
Truist Securities 06 Jan 2025 290.00 (8.68%) Hold 264.29

No data within this time range.

  • 3M
Date Type Details
03 Apr 2025 Announcement Humana Inc. Announces Dates for First Quarter 2025 Earnings and June Investor Conference
20 Mar 2025 Announcement CenterWell Bringing Convenient, Personalized Health Care to Seniors at Gladstone Walmart
17 Mar 2025 Announcement CenterWell, Icon Health Collaborate to Transform Musculoskeletal Care for Seniors
05 Mar 2025 Announcement AM Best Assigns Issue Credit Ratings to Humana Inc.’s New Senior Unsecured Notes
05 Mar 2025 Announcement Humana Completes Aggregate $1.25 Billion Debt Offering
03 Mar 2025 Announcement Humana Prices $1.25 Billion Debt Offering
26 Feb 2025 Announcement Humana Expands Value-Based Oncology Care Through New Agreement with Thyme Care
24 Feb 2025 Announcement Humana Foundation Donates $250,000 to Support Disaster Recovery in the Wake of Catastrophic Flooding in Kentucky
20 Feb 2025 Announcement Humana Board Declares Payment of Quarterly Dividend to Stockholders
19 Feb 2025 Announcement CenterWell Poised for Further Primary Care Expansion in 2025
13 Feb 2025 CNBC CVS shares are up 45% this year — here's why it may be starting to turn its business around
13 Feb 2025 Announcement Humana and Monogram Health Announce Expansion of Comprehensive Kidney Care Program
12 Feb 2025 CNBC CVS shares pop 15% on big earnings beat, even as high medical costs drag down insurance unit
11 Feb 2025 Announcement Humana Reports Fourth Quarter 2024 Financial Results; Provides Full Year 2025 Financial Guidance
05 Feb 2025 Announcement Value-Based Care Simplifies Healthcare for Patients and Clinicians, New Report Finds
04 Feb 2025 Announcement ASSOCIATION OF PICKLEBALL PLAYERS AND HUMANA ANNOUNCE MULTI-YEAR PARTNERSHIP EXTENSION
09 Jan 2025 Announcement Humana Inc. to Release Fourth Quarter 2024 Results on February 11, 2025
07 Jan 2025 Announcement Humana Earns Equality 100 Award in Human Rights Campaign Foundation’s 2025 Corporate Equality Index
Show more
TTM Dividend Yield 1.33%
5Y Average Dividend Yield 0.75%
Payout Ratio 35.47%
Expected Next Dividend Payment Jul 2025
Ex Date Announcement Date Payment Date Details
28 Mar 2025 20 Feb 2025 25 Apr 2025 0.885 Cash
31 Dec 2024 24 Oct 2024 31 Jan 2025 0.885 Cash
30 Sep 2024 15 Aug 2024 25 Oct 2024 0.885 Cash
28 Jun 2024 18 Apr 2024 26 Jul 2024 0.885 Cash
27 Mar 2024 15 Feb 2024 26 Apr 2024 0.885 Cash
28 Dec 2023 31 Oct 2023 26 Jan 2024 0.885 Cash
28 Sep 2023 17 Aug 2023 27 Oct 2023 0.885 Cash
29 Jun 2023 20 Apr 2023 28 Jul 2023 0.885 Cash
30 Mar 2023 16 Feb 2023 28 Apr 2023 0.885 Cash
29 Dec 2022 27 Oct 2022 27 Jan 2023 0.7875 Cash
29 Sep 2022 18 Aug 2022 28 Oct 2022 0.7875 Cash
29 Jun 2022 21 Apr 2022 29 Jul 2022 0.7875 Cash
30 Mar 2022 17 Feb 2022 29 Apr 2022 0.7875 Cash
30 Dec 2021 28 Oct 2021 28 Jan 2022 0.7 Cash
29 Jun 2021 22 Apr 2021 30 Jul 2021 0.7 Cash
30 Mar 2021 18 Feb 2021 30 Apr 2021 0.7 Cash
30 Dec 2020 03 Nov 2020 29 Jan 2021 0.625 Cash
29 Sep 2020 20 Aug 2020 30 Oct 2020 0.625 Cash
29 Jun 2020 23 Apr 2020 31 Jul 2020 0.625 Cash
30 Mar 2020 20 Feb 2020 24 Apr 2020 0.625 Cash
30 Dec 2019 24 Oct 2019 31 Jan 2020 0.55 Cash
27 Sep 2019 22 Aug 2019 25 Oct 2019 0.55 Cash
27 Jun 2019 19 Apr 2019 26 Jul 2019 0.55 Cash
28 Mar 2019 07 Feb 2019 26 Apr 2019 0.55 Cash
28 Dec 2018 03 Nov 2018 25 Jan 2019 0.5 Cash
27 Sep 2018 17 Aug 2018 26 Oct 2018 0.5 Cash
28 Jun 2018 20 Apr 2018 27 Jul 2018 0.5 Cash
28 Mar 2018 07 Feb 2018 27 Apr 2018 0.5 Cash
28 Dec 2017 02 Nov 2017 26 Jan 2018 0.4 Cash
28 Sep 2017 17 Aug 2017 27 Oct 2017 0.4 Cash
28 Jun 2017 20 Apr 2017 31 Jul 2017 0.4 Cash
29 Mar 2017 14 Feb 2017 28 Apr 2017 0.4 Cash
10 Jan 2017 26 Oct 2016 27 Jan 2017 0.29 Cash
11 Oct 2016 25 Aug 2016 28 Oct 2016 0.29 Cash
28 Jun 2016 21 Apr 2016 29 Jul 2016 0.29 Cash
29 Mar 2016 18 Feb 2016 29 Apr 2016 0.29 Cash
28 Dec 2015 29 Oct 2015 29 Jan 2016 0.29 Cash
28 Sep 2015 27 Aug 2015 30 Oct 2015 0.29 Cash
26 Jun 2015 17 Apr 2015 31 Jul 2015 0.29 Cash
27 Mar 2015 18 Feb 2015 24 Apr 2015 0.28 Cash
29 Dec 2014 31 Oct 2014 30 Jan 2015 0.28 Cash
26 Sep 2014 27 Aug 2014 31 Oct 2014 0.28 Cash
26 Jun 2014 30 Apr 2014 25 Jul 2014 0.28 Cash
27 Mar 2014 19 Feb 2014 25 Apr 2014 0.27 Cash
27 Dec 2013 30 Oct 2013 31 Jan 2014 0.27 Cash
26 Sep 2013 22 Aug 2013 25 Oct 2013 0.27 Cash
26 Jun 2013 25 Apr 2013 26 Jul 2013 0.27 Cash
26 Mar 2013 27 Feb 2013 26 Apr 2013 0.26 Cash
27 Dec 2012 18 Oct 2012 25 Jan 2013 0.26 Cash
26 Sep 2012 24 Aug 2012 26 Oct 2012 0.26 Cash
27 Jun 2012 30 Apr 2012 27 Jul 2012 0.26 Cash
28 Mar 2012 24 Feb 2012 27 Apr 2012 0.25 Cash
28 Dec 2011 24 Oct 2011 31 Jan 2012 0.25 Cash
28 Sep 2011 19 Aug 2011 28 Oct 2011 0.25 Cash
28 Jun 2011 26 Apr 2011 28 Jul 2011 0.25 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2025 1.77 2 0.66
2024 3.54 4 1.40
2023 3.44 4 0.75
2022 3.06 4 0.60
2021 2.03 3 0.44
2020 2.43 4 0.59
2019 2.15 4 0.59
2018 1.90 4 0.66
2017 1.49 4 0.60
2016 1.16 4 0.57
2015 1.14 4 0.64
2014 1.10 4 0.77
2013 1.06 4 1.03
2012 1.02 4 1.49
2011 0.500 2 0.57
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria